MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $298,370 | -1.2% | 1,065 | -5.8% | 0.12% | +1.7% |
| Q1 2024 | $302,022 | +8.7% | 1,131 | -5.8% | 0.12% | -0.8% |
| Q4 2023 | $277,887 | -90.9% | 1,201 | -94.3% | 0.12% | -79.8% |
| Q3 2023 | $3,052,382 | -30.4% | 20,901 | +10.1% | 0.59% | -18.7% |
| Q2 2023 | $4,385,535 | +3520.5% | 18,985 | +3697.0% | 0.73% | +3078.3% |
| Q1 2023 | $121,130 | -97.7% | 500 | -98.8% | 0.02% | -96.4% |
| Q1 2019 | $5,322,000 | +65.7% | 42,487 | +49.1% | 0.64% | +46.8% |
| Q4 2018 | $3,211,000 | -42.1% | 28,487 | +10.0% | 0.44% | -25.9% |
| Q3 2018 | $5,543,000 | -48.1% | 25,887 | -32.1% | 0.59% | -50.7% |
| Q2 2018 | $10,670,000 | +80.4% | 38,149 | -24.7% | 1.19% | +83.8% |
| Q1 2018 | $5,915,000 | +74.9% | 50,649 | +37.4% | 0.65% | +53.4% |
| Q4 2017 | $3,382,000 | – | 36,850 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |